Alembic Pharmaceuticals gets ANDA approval for Telmisartan and Amlodipine Tablets

From USFDA
Alembic Pharmaceuticals has received approval for its abbreviated new drug application (ANDA) for Telmisartan and Amlodipine Tablets, 40mg/5mg, 40mg/10mg, 80mg/5mg and 80mg/10mg from the United States Food and Drug Administration. The tablets are indicated for the treatment of hypertension, alone or with antihypertensive agents to reduce blood pressure.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 18 2016 | 4:39 PM IST
